These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13431902)

  • 21. Excretion of phenylalanine and derivatives in phenylpyruvic oligophrenia.
    JERVIS GA
    Proc Soc Exp Biol Med; 1950 Oct; 75(1):83-6. PubMed ID: 14797744
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolic disorders and hypopigmentation in phenylpyruvic oligophrenia].
    DELAY J; PICHOT P
    Sem Hop; 1950 Jun; 26(41):1962-7. PubMed ID: 15442334
    [No Abstract]   [Full Text] [Related]  

  • 23. The excretion of 5-hydroxyindoleacetic acid in the heterozygous carrier for phenylketonuria.
    HSIA DY; ROWLEY WA; HUANG I
    J Ment Defic Res; 1961 Jun; 5():4-9. PubMed ID: 13716364
    [No Abstract]   [Full Text] [Related]  

  • 24. Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria.
    FITZPATRICK TB; MIYAMOTO M
    Nature; 1957 Jan; 179(4552):199-200. PubMed ID: 13400136
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic errors and mental retardation.
    CARVER MJ; WITTSON C
    Clin Med (Northfield); 1961 Nov; 8():2109-16. PubMed ID: 13877025
    [No Abstract]   [Full Text] [Related]  

  • 26. [A form of mental deficiency of metabolic origin].
    BICKEL H
    Dtsch Med J; 1956 Jun; 7(11-12):414-6. PubMed ID: 13344233
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenylketonuria VIII. Relation between age, serum phenylalanine level, and phenylpyruvic acid excretion.
    ARMSTRONG MD; LOW NL
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):142-6. PubMed ID: 13400895
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pathogenetic problem of phenylpyruvic oligophrenia].
    Cumer Bruno S; Bruno A
    Riv Neurobiol; 1966; 12(4):529-88. PubMed ID: 5994783
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amino acid imbalance as a pathogenetic factor in mental retardation (author's transl)].
    Fekete G
    Klin Wochenschr; 1974 May; 52(6):276-82. PubMed ID: 4408538
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenylalanine metabolism in the phenylpyruvic condition. I. Distribution, pool size, and turnover rate in human phenylketonuria.
    GRUMER HD; KOBLET H; WOODARD C
    J Clin Invest; 1961 Sep; 40(9):1758-65. PubMed ID: 13709234
    [No Abstract]   [Full Text] [Related]  

  • 31. Phenylketonuria: the phenylalanine-tyrosine ratio in the detection of the heterozygous carrier.
    HSIA DY
    J Ment Defic Res; 1958 Jun; 2(1):8-16. PubMed ID: 13576048
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on phenylpyruvic oligophrenia; phenylpyruvic acid content on blood.
    JERVIS GA
    Proc Soc Exp Biol Med; 1952 Dec; 81(3):715-20. PubMed ID: 13037777
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.
    Curtius HC; Völlmin JA; Baerlocher K
    Clin Chim Acta; 1972 Mar; 37():277-85. PubMed ID: 5022091
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship of serum phenylalanine levels and ability of phenylketonurics to hydroxylate tryptophan.
    BALDRIDGE RC; BOROFSKY L; BAIRD H; REICHLE F; BULLOCK D
    Proc Soc Exp Biol Med; 1959 Mar; 100(3):529-31. PubMed ID: 13634197
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of phenylalanine and phenylpyruvic acid in the blood and urine. Application to two cases of phenylpyruvic oligophrenia].
    BISAZ S
    Helv Paediatr Acta; 1959 Sep; 14():282-7. PubMed ID: 13800954
    [No Abstract]   [Full Text] [Related]  

  • 36. The enzymic conversion of phenylalanine to tyrosine.
    KAUFMAN S
    Biochim Biophys Acta; 1957 Feb; 23(2):445-6. PubMed ID: 13412751
    [No Abstract]   [Full Text] [Related]  

  • 37. [Phenylpyruvic oligophrenia: new biochemical research].
    GUIDA A; CAMPAGNARI F; FERRARI V
    G Psichiatr Neuropatol; 1955; 83(2):375-7. PubMed ID: 13251537
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenylalanine-restricted diets in the treatment of phenylketonuria.
    BLAINEY JD; GULLIFORD R
    Arch Dis Child; 1956 Dec; 31(160):452-66. PubMed ID: 13395572
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria.
    ARMSTRONG MD; TYLER FH
    J Clin Invest; 1955 Apr; 34(4):565-80. PubMed ID: 14367510
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phenylalanine and tyrosine in albino rat brain in the normal state and in experimental phenylketonuria].
    Kaplanskiĭ SIa; Akopian ZhI
    Ukr Biokhim Zh; 1967; 39(1):34-7. PubMed ID: 5628879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.